BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernardi S, Giudici F, Colombin G, Cavallaro M, Stacul F, Fabris B. Residual vital ratio predicts 5-year volume reduction and retreatment after radiofrequency ablation of benign thyroid nodules but not regrowth. Int J Hyperthermia 2021;38:111-3. [PMID: 33530757 DOI: 10.1080/02656736.2021.1876931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kuo EJ, Oh A, Hu Y, McManus CM, Lee JA, Kuo JH. If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules. Surgery 2023;173:201-6. [PMID: 36334980 DOI: 10.1016/j.surg.2022.08.048] [Reference Citation Analysis]
2 Yan L, Luo Y. Response to letter to the editor from Dr. Bernardi regarding suitability of residual vital ratio for prediction of local regrowth following radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia 2021;38:189-90. [PMID: 33576298 DOI: 10.1080/02656736.2021.1883128] [Reference Citation Analysis]
3 Bernardi S, Palermo A, Grasso RF, Fabris B, Stacul F, Cesareo R. Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review. Cancers (Basel) 2021;13:2746. [PMID: 34205994 DOI: 10.3390/cancers13112746] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]